Milk Products Containing Bioactive Tripeptides Have an Antihypertensive Effect in Double Transgenic Rats (dTGR) Harbouring Human Renin and Human Angiotensinogen Genes

Tripeptides isoleucyl-prolyl-proline (IPP) and valyl-prolyl-proline (VPP) act as ACE inhibitors in vitro. Double transgenic rats (dTGR) harbouring human renin and human angiotensinogen genes develop malignant hypertension due to increased angiotensin II formation. The present study was aimed to eval...

Full description

Saved in:
Bibliographic Details
Main Authors: Tiina Jauhiainen, Taru Pilvi, Zhong Jian Cheng, Hannu Kautiainen, Dominik N. Müller, Heikki Vapaatalo, Riitta Korpela, Eero Mervaala
Format: Article
Language:English
Published: Wiley 2010-01-01
Series:Journal of Nutrition and Metabolism
Online Access:http://dx.doi.org/10.1155/2010/287030
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832551284792623104
author Tiina Jauhiainen
Taru Pilvi
Zhong Jian Cheng
Hannu Kautiainen
Dominik N. Müller
Heikki Vapaatalo
Riitta Korpela
Eero Mervaala
author_facet Tiina Jauhiainen
Taru Pilvi
Zhong Jian Cheng
Hannu Kautiainen
Dominik N. Müller
Heikki Vapaatalo
Riitta Korpela
Eero Mervaala
author_sort Tiina Jauhiainen
collection DOAJ
description Tripeptides isoleucyl-prolyl-proline (IPP) and valyl-prolyl-proline (VPP) act as ACE inhibitors in vitro. Double transgenic rats (dTGR) harbouring human renin and human angiotensinogen genes develop malignant hypertension due to increased angiotensin II formation. The present study was aimed to evaluate possible antihypertensive effect of IPP and VPP in this severe model. Four-week-old dTGR were randomized in three groups to receive: (1) water (control), (2) fermented milk containing IPP and VPP, and (3) IPP and VPP dissolved in water for three weeks. Fermented milk, but not peptides in water, attenuated the development of hypertension in dTGR by 19 mmHg versus the control group (P=.023). In vitro vascular function tests showed that high concentrations of the peptides evinced ACE inhibitory properties. In other hypertension related variables, no significant differences between the treatment groups were found. In conclusion, fermented milk product containing IPP and VPP prevents development of malignant hypertension in an animal model.
format Article
id doaj-art-d0f3b5825f8546e5bbee2f45c7db48ae
institution Kabale University
issn 2090-0724
2090-0732
language English
publishDate 2010-01-01
publisher Wiley
record_format Article
series Journal of Nutrition and Metabolism
spelling doaj-art-d0f3b5825f8546e5bbee2f45c7db48ae2025-02-03T06:01:50ZengWileyJournal of Nutrition and Metabolism2090-07242090-07322010-01-01201010.1155/2010/287030287030Milk Products Containing Bioactive Tripeptides Have an Antihypertensive Effect in Double Transgenic Rats (dTGR) Harbouring Human Renin and Human Angiotensinogen GenesTiina Jauhiainen0Taru Pilvi1Zhong Jian Cheng2Hannu Kautiainen3Dominik N. Müller4Heikki Vapaatalo5Riitta Korpela6Eero Mervaala7Institute of Biomedicine, Pharmacology, University of Helsinki, 00014 Helsinki, FinlandInstitute of Biomedicine, Pharmacology, University of Helsinki, 00014 Helsinki, FinlandInstitute of Biomedicine, Pharmacology, University of Helsinki, 00014 Helsinki, FinlandMedcare Oy, 44100 Äänekoski, FinlandMax Delbruck Center for Molecular Medicine, 13125 Berlin, GermanyInstitute of Biomedicine, Pharmacology, University of Helsinki, 00014 Helsinki, FinlandInstitute of Biomedicine, Pharmacology, University of Helsinki, 00014 Helsinki, FinlandInstitute of Biomedicine, Pharmacology, University of Helsinki, 00014 Helsinki, FinlandTripeptides isoleucyl-prolyl-proline (IPP) and valyl-prolyl-proline (VPP) act as ACE inhibitors in vitro. Double transgenic rats (dTGR) harbouring human renin and human angiotensinogen genes develop malignant hypertension due to increased angiotensin II formation. The present study was aimed to evaluate possible antihypertensive effect of IPP and VPP in this severe model. Four-week-old dTGR were randomized in three groups to receive: (1) water (control), (2) fermented milk containing IPP and VPP, and (3) IPP and VPP dissolved in water for three weeks. Fermented milk, but not peptides in water, attenuated the development of hypertension in dTGR by 19 mmHg versus the control group (P=.023). In vitro vascular function tests showed that high concentrations of the peptides evinced ACE inhibitory properties. In other hypertension related variables, no significant differences between the treatment groups were found. In conclusion, fermented milk product containing IPP and VPP prevents development of malignant hypertension in an animal model.http://dx.doi.org/10.1155/2010/287030
spellingShingle Tiina Jauhiainen
Taru Pilvi
Zhong Jian Cheng
Hannu Kautiainen
Dominik N. Müller
Heikki Vapaatalo
Riitta Korpela
Eero Mervaala
Milk Products Containing Bioactive Tripeptides Have an Antihypertensive Effect in Double Transgenic Rats (dTGR) Harbouring Human Renin and Human Angiotensinogen Genes
Journal of Nutrition and Metabolism
title Milk Products Containing Bioactive Tripeptides Have an Antihypertensive Effect in Double Transgenic Rats (dTGR) Harbouring Human Renin and Human Angiotensinogen Genes
title_full Milk Products Containing Bioactive Tripeptides Have an Antihypertensive Effect in Double Transgenic Rats (dTGR) Harbouring Human Renin and Human Angiotensinogen Genes
title_fullStr Milk Products Containing Bioactive Tripeptides Have an Antihypertensive Effect in Double Transgenic Rats (dTGR) Harbouring Human Renin and Human Angiotensinogen Genes
title_full_unstemmed Milk Products Containing Bioactive Tripeptides Have an Antihypertensive Effect in Double Transgenic Rats (dTGR) Harbouring Human Renin and Human Angiotensinogen Genes
title_short Milk Products Containing Bioactive Tripeptides Have an Antihypertensive Effect in Double Transgenic Rats (dTGR) Harbouring Human Renin and Human Angiotensinogen Genes
title_sort milk products containing bioactive tripeptides have an antihypertensive effect in double transgenic rats dtgr harbouring human renin and human angiotensinogen genes
url http://dx.doi.org/10.1155/2010/287030
work_keys_str_mv AT tiinajauhiainen milkproductscontainingbioactivetripeptideshaveanantihypertensiveeffectindoubletransgenicratsdtgrharbouringhumanreninandhumanangiotensinogengenes
AT tarupilvi milkproductscontainingbioactivetripeptideshaveanantihypertensiveeffectindoubletransgenicratsdtgrharbouringhumanreninandhumanangiotensinogengenes
AT zhongjiancheng milkproductscontainingbioactivetripeptideshaveanantihypertensiveeffectindoubletransgenicratsdtgrharbouringhumanreninandhumanangiotensinogengenes
AT hannukautiainen milkproductscontainingbioactivetripeptideshaveanantihypertensiveeffectindoubletransgenicratsdtgrharbouringhumanreninandhumanangiotensinogengenes
AT dominiknmuller milkproductscontainingbioactivetripeptideshaveanantihypertensiveeffectindoubletransgenicratsdtgrharbouringhumanreninandhumanangiotensinogengenes
AT heikkivapaatalo milkproductscontainingbioactivetripeptideshaveanantihypertensiveeffectindoubletransgenicratsdtgrharbouringhumanreninandhumanangiotensinogengenes
AT riittakorpela milkproductscontainingbioactivetripeptideshaveanantihypertensiveeffectindoubletransgenicratsdtgrharbouringhumanreninandhumanangiotensinogengenes
AT eeromervaala milkproductscontainingbioactivetripeptideshaveanantihypertensiveeffectindoubletransgenicratsdtgrharbouringhumanreninandhumanangiotensinogengenes